Skip to main content
logo
Profound Medical Corp. (TSX:PRN)
Canada flag Canada · Delayed Price · Currency is CAD
8.22
-0.87 (-9.57%)
Apr 10, 2026, 3:59 PM EST

Profound Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
6.372.440.3923.15
Other Revenue
9.738.246.814.683.72
Revenue
16.110.687.26.686.87
Revenue Growth (YoY)
50.73%48.35%7.75%-2.79%-5.90%
Cost of Revenue
4.713.642.893.663.92
Gross Profit
11.397.044.313.022.95
Selling, General & Admin
32.0523.1318.5417.9317.97
Research & Development
20.616.9714.4214.6915.28
Operating Expenses
52.6540.132.9632.6233.24
Operating Income
-41.25-33.06-28.65-29.6-30.29
Interest Expense
----0.17-0.07
Interest & Investment Income
1.071.440.780.80.21
Currency Exchange Gain (Loss)
-2.133.81-0.583.1-0.29
Other Non Operating Income (Expenses)
---0.02-0.16
EBT Excluding Unusual Items
-42.32-27.82-28.45-25.86-30.59
Impairment of Goodwill
----2.52-
Pretax Income
-42.32-27.82-28.45-28.38-30.59
Income Tax Expense
0.25-0-0.130.290.11
Net Income
-42.57-27.82-28.32-28.67-30.7
Net Income to Common
-42.57-27.82-28.32-28.67-30.7
Shares Outstanding (Basic)
3025212120
Shares Outstanding (Diluted)
3025212120
Shares Change (YoY)
22.08%16.91%1.69%1.79%18.33%
EPS (Basic)
-1.41-1.12-1.34-1.38-1.50
EPS (Diluted)
-1.41-1.12-1.34-1.38-1.50
Free Cash Flow
-38.38-23.45-22.61-25.8-22.39
Free Cash Flow Per Share
-1.27-0.95-1.07-1.24-1.09
Gross Margin
70.77%65.89%59.90%45.22%42.95%
Operating Margin
-256.27%-309.57%-397.99%-443.08%-440.73%
Profit Margin
-264.44%-260.45%-393.43%-429.11%-446.66%
Free Cash Flow Margin
-238.43%-219.60%-314.06%-386.17%-325.80%
EBITDA
-40.69-32.13-27.72-28.83-29.61
EBITDA Margin
-252.79%----
D&A For EBITDA
0.560.940.930.780.68
EBIT
-41.25-33.06-28.65-29.6-30.29
EBIT Margin
-256.27%----
Revenue as Reported
16.110.687.26.686.87
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.